Dr. Rajesh Davé is a recognized leader in cardiovascular intervention, and currently serves as Chairman, Department of Cardiology and Chief Medical Executive of Holy Spirit Cardiovascular Institute at Holy Spirit Hospital, Camp Hill, PA, USA. He is founder and chairman of the Complex Cardiovascular Catheter Therapeutics congress, known as C3. He is a frequent speaker for cardiovascular conferences around the world and has given hundreds of lectures. He is a pioneer in endovascular intervention, especially critical limb ischemia, limb salvage and carotid artery stenting. He has performed over 10,000 interventional procedures in his career. He has advised medical device start-ups regarding the designs of current and future products. He has served as Principal Investigator for a variety of clinical trials. He has authored many manuscripts and book chapters, and he serves on the editorial boards of numerous medical journals.

Dr Magdi El-Omar is a consultant interventional cardiologist at the Manchester Heart Centre and an honorary senior lecturer at the University of Manchester, Manchester, UK. He graduated from St Bartholomew’s Hospital, London, UK, in 1988 and undertook his postgraduate general medical training in London and Oxford. He then completed his general cardiology training in Birmingham, Oxford and Wales before subspecializing in coronary intervention. The latter included a 2.5-year clinical/research fellowship in interventional cardiology at the Cardiovascular Research Foundation and the New York University Medical Centre, New York, NY, USA. During his time there, he worked closely with leaders in the field, including doctors Greg Stone, Martin Leon, Gary Roubin, Frederick Feit and Aaron Marcus. Dr El-Omar has been involved in research for over 25 years. He undertook a 2-year British Heart Foundation Junior Research Fellowship in basic science (diabetic cardiomyopathy in a rat model) in 1997–8, which led to the award of an MD degree from the University of London. He has since been actively involved in clinical research, especially in the fields of acute coronary syndromes and coronary intervention. He has authored more than 70 peer-reviewed articles, mostly in high-impact journals. He has been a local principal investigator for several landmark, international, multicentre trials (e.g. HORIZONS-AMI, INFUSE-AMI, TOTAL, TWILIGHT, etc.). He is actively involved in education and training and is a course co-director of the International Complex Cardiovascular Catheter Therapeutics Conference in the USA.

Dr Samaja is a distinguished cardiologist and interventional radiologist, currently serving as the Chief of the Department of Interventional Radiology and Cardiology at Policlinico Bancario in Buenos Aires, Argentina. In addition, he is the Director of the Cardiac Catheterization Laboratory at “Sanatorio Colegiales” in Buenos AiresConsultant in Cardiovascular Disease at the “Dirección General de Obra Social del Servicio Penitenciario Federal” and various other public, union, and private health structures throughout Argentina. 

Dr Samaja is an active member of several prestigious professional organizations, including the Sociedad Argentina de Cardiología (SAC), Colegio Argentino de Cardioangiólogos Intervencionistas (CACI), and Sociedad Latinoamericana de Cardiología Intervencionista (SOLACI). Additionally, he is a Fellow of The Society for Cardiovascular Angiography and Interventions (SCAI) and a member of Heart International.

As a founder member of the Interventional Academy, Dr Samaja has made significant contributions to the field of interventional cardiology. He has held over fifty faculty appointments at international scientific meetings, including CIT since 2009, C3 Orlando since 2012, and has been a faculty member at EuroPCR, TCT, India Live, Egypt, and various other meetings in Argentina, South America, and overseas.

Dr Samaja has an extensive record of scholarly contributions, with more than fifty cases, abstracts, and poster presentations as an author or coauthor at scientific meetings. His expertise and commitment to advancing cardiovascular care have made him a respected leader in his field.

Dr Timir Paul is a Professor of Medicine and Founding Program Director for Cardiology Fellowship at University of Tennessee Health Sciences Center at Nashville. After receiving MD, he was awarded PhD and MPH in Cardiovascular Epidemiology by Tulane University. He has served as the Founding Co-Director of the Center for Cardiovascular Risk Research at East Tennessee State University.  He has authored and coauthored more than 200 publications and book chapters.  He serves as an academic editor for PLOS ONE Journal and on the Editorial Board for several Cardiology Journals including Journal of the Society of Coronary Angiography and Intervention, Catheterization and Cardiovascular Intervention, Cardiovascular Revascularization Medicine and Heart International. His research and recommendations changed the 2021 ACC/AHA 2021 and 2018 European Society of Cardiology guidelines on coronary revascularization by downgrading the use of embolic protection device in vein graft intervention from Class I to Class IIa. He received several grants including a PCORI grant and a 4.5 million dollars AHRQ grant as a co-investigator. His research interests include vein graft interventions, embolic protection devices in coronary and peripheral interventions, subclinical atherosclerosis, coronary microvascular disease, and renal artery interventions. He was recognized as SCAI-Emerging Leader Mentorship Program Circle member and Young Leader by the Cardiovascular Revascularization Technologies. He is an invitee of the 2022 and 2023 ACC Leadership Forum. He received the best teaching award given by cardiology fellows for the 4 consecutive years. He was inducted by Alpha Omega Alpha Medical Honor Society as a faculty member. He received Dean’s distinguished research award. He is an invited faculty for national and international scientific conferences including SCAI, ACC, AHA and CRT. He serves on the SCAI QI and International Committee and ACC PDGME Leadership Council.

Bryan W Kluck, DO,FACC,FSCAI is a practicing Interventional Cardiologist in Allentown and Harrisburg Pennsylvania for 40 years. Strong interest in both fellow and continuing education as  the 15 year Co-Director of the C3 International Cardiovascular Conference and 4 time teacher of the year at Lehigh Valley Hospital. Current clinical interests include Endovenous intervention and treatment of Patent Foramen Ovale and Atrial Septal Defect.

Dr. Erik Wissner, MD, PhD, Associate Professor of Medicine at the University of Illinois at Chicago serves as the Director of Electrophysiology in the Division of Cardiology. He has a particular interest in complex arrhythmia management and special expertise in catheter ablation of complex atrial and ventricular arrhythmias. His research interests relate to the clinical assessment of novel mapping and ablation technologies.

Joachim R Ehrlich MD is currently Head of Cardiology and Electrophysiology at St Josefs-Hospital, Wiesbaden, Germany. He completed his internship and residency training in medicine in 2001 at Goethe-University, Frankfurt, Germany and gained a fellowship in basic cardiac electrophysiology at the Montreal Heart Institute, Montreal, Canada. Following a fellowship in cardiology at Goethe-University, Dr Ehrlich gained German Cardiac Society certifications in interventional cardiology and electrophysiology in 2014. Dr Ehrlich has specific scientific expertise in basic cardiac electrophysiology, with a focus on atrial fibrillation research. He is also highly experienced in pharmacological management of cardiac arrhythmias, oral anticoagulation, cardiac resynchronisation therapy, genetically determined cardiac arrhythmia syndromes and risk stratification for sudden cardiac death. Dr Ehrlich is a Fellow of several scientific organisations, including the American Heart Association, the Heart Rhythm Society, the European Heart Rhythm Association and the European Society of Cardiology, among others. He is on the editorial boards of several scientific journals, including Heart Rhythm, the Canadian Journal of Cardiology and the European Journal of Arrhythmia & Electrophysiology.

Krzysztof J. Filipiak, MD, PhD, FESC, is a specialist in cardiology, internal medicine, hypertensiology, and clinical pharmacology. He graduated from the Medical University of Warsaw, starting his career in the Department of Experimental and Clinical Pharmacology, and subsequently in the 1st Chair and Department of Cardiology, where he currently holds professor position. Research and clinical internships in: Utrecht, Amsterdam, Rio de Janeiro, Geneva, Milan. Since 2012, Prof. Filipiak is the Vice Dean for Science in the 1st Faculty of Medicine, Medical University of Warsaw. In Polish Cardiac Society (PCS), prof. Filipiak was the Chairman of Polish Top Junior Cardiologists “Club 30”, Chairman of PCS Section for Cardiovascular Pharmacotherapy, member of the Main Board, and the Treasurer of PCS. In European Society of Cardiology, he is a member of two working groups: on Acute Cardiac Care and on Cardiovascular Pharmacology and Drug Therapy. Serves as the member of the Main Board in Polish Society of Hypertension. His main interests include: acute coronary syndromes, arterial hypertension, dyslipidaemias, heart failure, stable angina, cardiovascular pharmacotherapy, evidence-based medicine methodology. Co-editor of several textbooks, including first Polish complete monography on statins (“Statins – the clinical pharmacology”), and co-author of over 190 papers indexed in PubMed MEDLINE; according to Google Scholar database (April, 2015): 1640 citations, Hirsch index=18, i-10 index=36. Since 2012, the Editor-in-chief of KARDIOLOGIA POLSKA [Polish Heart Journal] – the official journal of PCS.

Angelo Auricchio is Professor of Cardiology at University Hospital in Magdeburg, Germany and director of the Clinical Electrophysiology Unit at Fondazione Cardiocentro Ticino, Lugano, Switzerland. He is the immediate past President of European Heart Rhythm Association (EHRA).

Moreover, he is co-directing the Center for Computational Medicine in Cardiology at Università della Svizzera Italiana in Lugano, Switzerland. Furthermore, he is serving as Scientific Director at the Fondazione Ticino Cuore, an institution devoted to increase public awareness of out-of-hospital cardiac arrest victims and to improve the survival rate of victims of out-of hospital arrest.

He is the author of over 70 scientific review articles and book chapters and almost 200 original scientific papers.

He has served as a member of the Task Force for European Society of Cardiology Guidelines for Cardiac Pacing and Cardiac Resynchronization Therapy and as Chair of the EHRA Cardiac Rhythm Management Product Performance Task Force.